• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 6.25% 17.0¢

PHARMAUST LIMITED - Announcements

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Announcements


PAA Proposed issue of securities - PAA02/01/24 download Created with Sketch. 26.96KB
PAA Cleansing Prospectus & Target Market Determination02/01/24 download Created with Sketch. 401.66KB
PAA Cleansing Notice22/12/23 download Created with Sketch. 212.01KB
PAA Application for quotation of securities - PAA22/12/23 download Created with Sketch. 27.08KB
PAA FightMND Invites PharmAust to Apply for Phase 2/3 FundingPRICE SENSITIVE22/12/23 download Created with Sketch. 154.99KB
PAA Application for quotation of securities - PAA21/12/23 download Created with Sketch. 25.52KB
PAA Application for quotation of securities - PAA21/12/23 download Created with Sketch. 24.87KB
PAA PharmAust Receives R&D Tax Incentive RefundPRICE SENSITIVE20/12/23 download Created with Sketch. 152.85KB
PAA PAAOA Top 20 & Distribution Report19/12/23 download Created with Sketch. 104.26KB
PAA Appendix 3Y x 418/12/23 download Created with Sketch. 347.68KB
PAA Appendix 2A18/12/23 download Created with Sketch. 373.9KB
PAA PharmAust Launches Interactive Investor Hub18/12/23 download Created with Sketch. 138.79KB
PAA Cleansing Notice18/12/23 download Created with Sketch. 211.49KB
PAA Application for quotation of securities - PAA18/12/23 download Created with Sketch. 27KB
PAA Update - Proposed issue of securities - PAA18/12/23 download Created with Sketch. 30.2KB
PAA 93% take up in Options OfferPRICE SENSITIVE15/12/23 download Created with Sketch. 154.54KB
PAA Update - Proposed issue of securities - PAA14/12/23 download Created with Sketch. 27.31KB
PAA Proposed issue of securities - PAA13/12/23 download Created with Sketch. 30.15KB
PAA PharmAust Raises $3.5 Million at a PremiumPRICE SENSITIVE13/12/23 download Created with Sketch. 170.98KB
PAA Trading HaltPRICE SENSITIVE11/12/23 download Created with Sketch. 549.26KB
PAA New Hires & Attendance at International MND Symposium06/12/23 download Created with Sketch. 206.87KB
PAA PAA completes Phase 1 and files for Orphan Drug DesignationPRICE SENSITIVE01/12/23 download Created with Sketch. 184.1KB
PAA Prospectus & Target Market DeterminationPRICE SENSITIVE21/11/23 download Created with Sketch. 423KB
PAA Results of Annual General Meeting20/11/23 download Created with Sketch. 271.15KB
PAA Appendix 3Y x 406/11/23 download Created with Sketch. 258.57KB
PAA PharmAust to present at Emerging ASX Gems Conference02/11/23 download Created with Sketch. 178.51KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE30/10/23 download Created with Sketch. 3.11MB
PAA Application for quotation of securities - PAA27/10/23 download Created with Sketch. 24.8KB
PAA Notice of Annual General Meeting & Proxy Form19/10/23 download Created with Sketch. 541.63KB
PAA Proposed issue of securities - PAA18/10/23 download Created with Sketch. 27.42KB
PAA Options Offer to Existing Listed Option HoldersPRICE SENSITIVE18/10/23 download Created with Sketch. 331.86KB
PAA Final MND Patient in Cohort 4 Successfully Completes DosingPRICE SENSITIVE13/10/23 download Created with Sketch. 226.42KB
PAA Canine Oncology Data Supports Progression to RegistrationPRICE SENSITIVE09/10/23 download Created with Sketch. 1.18MB
PAA Trading HaltPRICE SENSITIVE06/10/23 download Created with Sketch. 524.8KB
PAA Clarification to notification of expiry of quoted options02/10/23 download Created with Sketch. 152.72KB
PAA Notification of expiry of quoted options29/09/23 download Created with Sketch. 160.72KB
PAA Change of registry address notification15/09/23 download Created with Sketch. 152.87KB
PAA Notification regarding unquoted securities - PAA08/09/23 download Created with Sketch. 31.85KB
PAA Cleansing Notice04/09/23 download Created with Sketch. 211.39KB
PAA Application for quotation of securities - PAA04/09/23 download Created with Sketch. 24.48KB
PAA Appendix 4G & Corporate Governance Statement31/08/23 download Created with Sketch. 588.23KB
PAA Appendix 4E & Full Year Statutory AccountsPRICE SENSITIVE31/08/23 download Created with Sketch. 1.21MB
PAA Chief Executive Officer AppointmentPRICE SENSITIVE28/08/23 download Created with Sketch. 209.6KB
PAA Release of Restricted Securities from Escrow25/08/23 download Created with Sketch. 183.72KB
PAA Additional Phase 1 data suggest MPL may inhibit MNDPRICE SENSITIVE22/08/23 download Created with Sketch. 351.67KB
PAA Trading HaltPRICE SENSITIVE17/08/23 download Created with Sketch. 552.24KB
PAA Cohort 3 Pharmacokinetics in MND Patients CompletedPRICE SENSITIVE09/08/23 download Created with Sketch. 305.56KB
PAA Epichem enters voluntary liquidationPRICE SENSITIVE01/08/23 download Created with Sketch. 149.19KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE31/07/23 download Created with Sketch. 1.58MB
PAA MND Trial Successfully Completes 3rd Patient CohortPRICE SENSITIVE28/07/23 download Created with Sketch. 183.55KB
PAA Canine Trial UpdatePRICE SENSITIVE13/07/23 download Created with Sketch. 1.23MB
PAA Results show MPL suppresses biomarkers associated with MNDPRICE SENSITIVE11/07/23 download Created with Sketch. 248.2KB
PAA Trading HaltPRICE SENSITIVE10/07/23 download Created with Sketch. 575.59KB
PAA Change of Director's Interest Notice x 307/07/23 download Created with Sketch. 230.77KB
PAA s708A(5)(e) notice07/07/23 download Created with Sketch. 204.09KB
PAA Notification of cessation of securities - PAA07/07/23 download Created with Sketch. 21.57KB
PAA Notification regarding unquoted securities - PAA07/07/23 download Created with Sketch. 25.64KB
PAA Application for quotation of securities - PAA07/07/23 download Created with Sketch. 24.77KB
PAA Louie the Beagle surpasses one year on MPLPRICE SENSITIVE06/07/23 download Created with Sketch. 440.49KB
PAA MND Biomarkers and Pharmacodynamics ResultsPRICE SENSITIVE04/07/23 download Created with Sketch. 341.97KB
PAA Results of General Meeting30/06/23 download Created with Sketch. 348.02KB
PAA Trading HaltPRICE SENSITIVE30/06/23 download Created with Sketch. 217.47KB
PAA General Meeting - Chairman Script30/06/23 download Created with Sketch. 255.48KB
PAA Motor Neurone Disease Phase 1/2 Clinical Trial UpdatePRICE SENSITIVE27/06/23 download Created with Sketch. 209.8KB
PAA Commencement of Cohort 3 in Phase 1/2 MND Trial09/06/23 download Created with Sketch. 203.06KB
PAA PharmAust MND Trial Interim Analysis PK OutcomesPRICE SENSITIVE07/06/23 download Created with Sketch. 364.64KB
PAA Trading HaltPRICE SENSITIVE05/06/23 download Created with Sketch. 578.64KB
PAA Notice of General Meeting/Proxy Form26/05/23 download Created with Sketch. 544.76KB
PAA Motor Neurone Disease Clinical Trial UpdatePRICE SENSITIVE22/05/23 download Created with Sketch. 206.61KB
PAA Securities issued under LR7.1 & LR7.1A16/05/23 download Created with Sketch. 193.78KB
PAA Progress update on Phase 1/2 MND interim analysisPRICE SENSITIVE16/05/23 download Created with Sketch. 258.68KB
PAA Application for quotation of securities - PAA11/05/23 download Created with Sketch. 27KB
PAA Cancel - Notification regarding unquoted securities - PAA11/05/23 download Created with Sketch. 27.12KB
PAA Notification regarding unquoted securities - PAA11/05/23 download Created with Sketch. 27.56KB
PAA Terms & Conditions of Unlisted Options11/05/23 download Created with Sketch. 94.11KB
PAA Appendix 3Y11/05/23 download Created with Sketch. 182.68KB
PAA Section 708(5) Notice11/05/23 download Created with Sketch. 203.85KB
PAA Notification regarding unquoted securities - PAA11/05/23 download Created with Sketch. 27.39KB
PAA Notification regarding unquoted securities - PAA11/05/23 download Created with Sketch. 27.22KB
PAA Application for quotation of securities - PAA11/05/23 download Created with Sketch. 24.55KB
PAA Independent tests show MPL retains long-term shelf-lifePRICE SENSITIVE10/05/23 download Created with Sketch. 274.33KB
PAA MPL has anti-cancer effects across multiple cancer typesPRICE SENSITIVE09/05/23 download Created with Sketch. 655.11KB
PAA Proposed issue of securities - PAA03/05/23 download Created with Sketch. 28.01KB
PAA PharmAust Raises $2.5m via PlacementPRICE SENSITIVE03/05/23 download Created with Sketch. 205.33KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE28/04/23 download Created with Sketch. 1.24MB
PAA Trading HaltPRICE SENSITIVE28/04/23 download Created with Sketch. 577.21KB
PAA MND Trial Successfully Completes Second Patient CohortPRICE SENSITIVE28/04/23 download Created with Sketch. 231.89KB
PAA Canine Trial UpdatePRICE SENSITIVE21/04/23 download Created with Sketch. 1.42MB
PAA Arrival of additional MPL tabletsPRICE SENSITIVE17/04/23 download Created with Sketch. 227.21KB
PAA PharmAust launches international CEO searchPRICE SENSITIVE13/04/23 download Created with Sketch. 234.9KB
PAA MND Trial Completes Enrolment of Cohort 2PRICE SENSITIVE30/03/23 download Created with Sketch. 209.15KB
PAA Stable Patient in MND trial reaches 6-months on MPLPRICE SENSITIVE28/03/23 download Created with Sketch. 200.46KB
PAA PharmAust Investor Webinar Presentation16/03/23 download Created with Sketch. 3.61MB
PAA AOG Energy Conference Presentation15/03/23 download Created with Sketch. 2.79MB
PAA Investor Webinar14/03/23 download Created with Sketch. 194.38KB
PAA Correction to Appendix 3Y13/03/23 download Created with Sketch. 183.17KB
PAA Change of Director's Interest Notice13/03/23 download Created with Sketch. 183.22KB
PAA Canine Cancer Trial UpdatePRICE SENSITIVE07/03/23 download Created with Sketch. 351.24KB
PAA Interim analysis recommended in MND trialPRICE SENSITIVE02/03/23 download Created with Sketch. 253.45KB
PAA European Patent relating to MPL Combinations in CancerPRICE SENSITIVE28/02/23 download Created with Sketch. 202KB
PAA Proposed issue of securities - PAA
02/01/24 download Created with Sketch. 26.96KB
PAA Cleansing Prospectus & Target Market Determination
02/01/24 download Created with Sketch. 401.66KB
PAA Cleansing Notice
22/12/23 download Created with Sketch. 212.01KB
PAA Application for quotation of securities - PAA
22/12/23 download Created with Sketch. 27.08KB
PAA FightMND Invites PharmAust to Apply for Phase 2/3 Funding
22/12/23PRICE SENSITIVE download Created with Sketch. 154.99KB
PAA Application for quotation of securities - PAA
21/12/23 download Created with Sketch. 25.52KB
PAA Application for quotation of securities - PAA
21/12/23 download Created with Sketch. 24.87KB
PAA PharmAust Receives R&D Tax Incentive Refund
20/12/23PRICE SENSITIVE download Created with Sketch. 152.85KB
PAA PAAOA Top 20 & Distribution Report
19/12/23 download Created with Sketch. 104.26KB
PAA Appendix 3Y x 4
18/12/23 download Created with Sketch. 347.68KB
PAA Appendix 2A
18/12/23 download Created with Sketch. 373.9KB
PAA PharmAust Launches Interactive Investor Hub
18/12/23 download Created with Sketch. 138.79KB
PAA Cleansing Notice
18/12/23 download Created with Sketch. 211.49KB
PAA Application for quotation of securities - PAA
18/12/23 download Created with Sketch. 27KB
PAA Update - Proposed issue of securities - PAA
18/12/23 download Created with Sketch. 30.2KB
PAA 93% take up in Options Offer
15/12/23PRICE SENSITIVE download Created with Sketch. 154.54KB
PAA Update - Proposed issue of securities - PAA
14/12/23 download Created with Sketch. 27.31KB
PAA Proposed issue of securities - PAA
13/12/23 download Created with Sketch. 30.15KB
PAA PharmAust Raises $3.5 Million at a Premium
13/12/23PRICE SENSITIVE download Created with Sketch. 170.98KB
PAA Trading Halt
11/12/23PRICE SENSITIVE download Created with Sketch. 549.26KB
PAA New Hires & Attendance at International MND Symposium
06/12/23 download Created with Sketch. 206.87KB
PAA PAA completes Phase 1 and files for Orphan Drug Designation
01/12/23PRICE SENSITIVE download Created with Sketch. 184.1KB
PAA Prospectus & Target Market Determination
21/11/23PRICE SENSITIVE download Created with Sketch. 423KB
PAA Results of Annual General Meeting
20/11/23 download Created with Sketch. 271.15KB
PAA Appendix 3Y x 4
06/11/23 download Created with Sketch. 258.57KB
PAA PharmAust to present at Emerging ASX Gems Conference
02/11/23 download Created with Sketch. 178.51KB
PAA Appendix 4C and Quarterly Update
30/10/23PRICE SENSITIVE download Created with Sketch. 3.11MB
PAA Application for quotation of securities - PAA
27/10/23 download Created with Sketch. 24.8KB
PAA Notice of Annual General Meeting & Proxy Form
19/10/23 download Created with Sketch. 541.63KB
PAA Proposed issue of securities - PAA
18/10/23 download Created with Sketch. 27.42KB
PAA Options Offer to Existing Listed Option Holders
18/10/23PRICE SENSITIVE download Created with Sketch. 331.86KB
PAA Final MND Patient in Cohort 4 Successfully Completes Dosing
13/10/23PRICE SENSITIVE download Created with Sketch. 226.42KB
PAA Canine Oncology Data Supports Progression to Registration
09/10/23PRICE SENSITIVE download Created with Sketch. 1.18MB
PAA Trading Halt
06/10/23PRICE SENSITIVE download Created with Sketch. 524.8KB
PAA Clarification to notification of expiry of quoted options
02/10/23 download Created with Sketch. 152.72KB
PAA Notification of expiry of quoted options
29/09/23 download Created with Sketch. 160.72KB
PAA Change of registry address notification
15/09/23 download Created with Sketch. 152.87KB
PAA Notification regarding unquoted securities - PAA
08/09/23 download Created with Sketch. 31.85KB
PAA Cleansing Notice
04/09/23 download Created with Sketch. 211.39KB
PAA Application for quotation of securities - PAA
04/09/23 download Created with Sketch. 24.48KB
PAA Appendix 4G & Corporate Governance Statement
31/08/23 download Created with Sketch. 588.23KB
PAA Appendix 4E & Full Year Statutory Accounts
31/08/23PRICE SENSITIVE download Created with Sketch. 1.21MB
PAA Chief Executive Officer Appointment
28/08/23PRICE SENSITIVE download Created with Sketch. 209.6KB
PAA Release of Restricted Securities from Escrow
25/08/23 download Created with Sketch. 183.72KB
PAA Additional Phase 1 data suggest MPL may inhibit MND
22/08/23PRICE SENSITIVE download Created with Sketch. 351.67KB
PAA Trading Halt
17/08/23PRICE SENSITIVE download Created with Sketch. 552.24KB
PAA Cohort 3 Pharmacokinetics in MND Patients Completed
09/08/23PRICE SENSITIVE download Created with Sketch. 305.56KB
PAA Epichem enters voluntary liquidation
01/08/23PRICE SENSITIVE download Created with Sketch. 149.19KB
PAA Appendix 4C and Quarterly Update
31/07/23PRICE SENSITIVE download Created with Sketch. 1.58MB
PAA MND Trial Successfully Completes 3rd Patient Cohort
28/07/23PRICE SENSITIVE download Created with Sketch. 183.55KB
PAA Canine Trial Update
13/07/23PRICE SENSITIVE download Created with Sketch. 1.23MB
PAA Results show MPL suppresses biomarkers associated with MND
11/07/23PRICE SENSITIVE download Created with Sketch. 248.2KB
PAA Trading Halt
10/07/23PRICE SENSITIVE download Created with Sketch. 575.59KB
PAA Change of Director's Interest Notice x 3
07/07/23 download Created with Sketch. 230.77KB
PAA s708A(5)(e) notice
07/07/23 download Created with Sketch. 204.09KB
PAA Notification of cessation of securities - PAA
07/07/23 download Created with Sketch. 21.57KB
PAA Notification regarding unquoted securities - PAA
07/07/23 download Created with Sketch. 25.64KB
PAA Application for quotation of securities - PAA
07/07/23 download Created with Sketch. 24.77KB
PAA Louie the Beagle surpasses one year on MPL
06/07/23PRICE SENSITIVE download Created with Sketch. 440.49KB
PAA MND Biomarkers and Pharmacodynamics Results
04/07/23PRICE SENSITIVE download Created with Sketch. 341.97KB
PAA Results of General Meeting
30/06/23 download Created with Sketch. 348.02KB
PAA Trading Halt
30/06/23PRICE SENSITIVE download Created with Sketch. 217.47KB
PAA General Meeting - Chairman Script
30/06/23 download Created with Sketch. 255.48KB
PAA Motor Neurone Disease Phase 1/2 Clinical Trial Update
27/06/23PRICE SENSITIVE download Created with Sketch. 209.8KB
PAA Commencement of Cohort 3 in Phase 1/2 MND Trial
09/06/23 download Created with Sketch. 203.06KB
PAA PharmAust MND Trial Interim Analysis PK Outcomes
07/06/23PRICE SENSITIVE download Created with Sketch. 364.64KB
PAA Trading Halt
05/06/23PRICE SENSITIVE download Created with Sketch. 578.64KB
PAA Notice of General Meeting/Proxy Form
26/05/23 download Created with Sketch. 544.76KB
PAA Motor Neurone Disease Clinical Trial Update
22/05/23PRICE SENSITIVE download Created with Sketch. 206.61KB
PAA Securities issued under LR7.1 & LR7.1A
16/05/23 download Created with Sketch. 193.78KB
PAA Progress update on Phase 1/2 MND interim analysis
16/05/23PRICE SENSITIVE download Created with Sketch. 258.68KB
PAA Application for quotation of securities - PAA
11/05/23 download Created with Sketch. 27KB
PAA Cancel - Notification regarding unquoted securities - PAA
11/05/23 download Created with Sketch. 27.12KB
PAA Notification regarding unquoted securities - PAA
11/05/23 download Created with Sketch. 27.56KB
PAA Terms & Conditions of Unlisted Options
11/05/23 download Created with Sketch. 94.11KB
PAA Appendix 3Y
11/05/23 download Created with Sketch. 182.68KB
PAA Section 708(5) Notice
11/05/23 download Created with Sketch. 203.85KB
PAA Notification regarding unquoted securities - PAA
11/05/23 download Created with Sketch. 27.39KB
PAA Notification regarding unquoted securities - PAA
11/05/23 download Created with Sketch. 27.22KB
PAA Application for quotation of securities - PAA
11/05/23 download Created with Sketch. 24.55KB
PAA Independent tests show MPL retains long-term shelf-life
10/05/23PRICE SENSITIVE download Created with Sketch. 274.33KB
PAA MPL has anti-cancer effects across multiple cancer types
09/05/23PRICE SENSITIVE download Created with Sketch. 655.11KB
PAA Proposed issue of securities - PAA
03/05/23 download Created with Sketch. 28.01KB
PAA PharmAust Raises $2.5m via Placement
03/05/23PRICE SENSITIVE download Created with Sketch. 205.33KB
PAA Appendix 4C and Quarterly Update
28/04/23PRICE SENSITIVE download Created with Sketch. 1.24MB
PAA Trading Halt
28/04/23PRICE SENSITIVE download Created with Sketch. 577.21KB
PAA MND Trial Successfully Completes Second Patient Cohort
28/04/23PRICE SENSITIVE download Created with Sketch. 231.89KB
PAA Canine Trial Update
21/04/23PRICE SENSITIVE download Created with Sketch. 1.42MB
PAA Arrival of additional MPL tablets
17/04/23PRICE SENSITIVE download Created with Sketch. 227.21KB
PAA PharmAust launches international CEO search
13/04/23PRICE SENSITIVE download Created with Sketch. 234.9KB
PAA MND Trial Completes Enrolment of Cohort 2
30/03/23PRICE SENSITIVE download Created with Sketch. 209.15KB
PAA Stable Patient in MND trial reaches 6-months on MPL
28/03/23PRICE SENSITIVE download Created with Sketch. 200.46KB
PAA PharmAust Investor Webinar Presentation
16/03/23 download Created with Sketch. 3.61MB
PAA AOG Energy Conference Presentation
15/03/23 download Created with Sketch. 2.79MB
PAA Investor Webinar
14/03/23 download Created with Sketch. 194.38KB
PAA Correction to Appendix 3Y
13/03/23 download Created with Sketch. 183.17KB
PAA Change of Director's Interest Notice
13/03/23 download Created with Sketch. 183.22KB
PAA Canine Cancer Trial Update
07/03/23PRICE SENSITIVE download Created with Sketch. 351.24KB
PAA Interim analysis recommended in MND trial
02/03/23PRICE SENSITIVE download Created with Sketch. 253.45KB
PAA European Patent relating to MPL Combinations in Cancer
28/02/23PRICE SENSITIVE download Created with Sketch. 202KB
(20min delay)
Last
17.0¢
Change
0.010(6.25%)
Mkt cap ! $82.65M
Open High Low Value Volume
16.0¢ 17.0¢ 15.5¢ $145.3K 876.8K

Buyers (Bids)

No. Vol. Price($)
1 38307 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 302337 3
View Market Depth
Last trade - 15.51pm 23/08/2024 (20 minute delay) ?
Last
17.0¢
  Change
0.010 ( 6.25 %)
Open High Low Volume
15.8¢ 17.5¢ 15.5¢ 225724
Last updated 15.46pm 23/08/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.